Clinical Nuclear Medicine · 2013 · 21 citations · 22 references
FLT PET does not appear to be recommendable to replace FDG PET for pretreatment metastasis staging in HNSCC cases because of its lower sensitivity and higher background activity in the liver and bone marrow. However, it might provide additional diagnostic specificity and biological information.
22
Gerald Antoch, Nina Saoudi, Hilmar Kuehl et al. · Journal of Clinical Oncology · 2004 · 431 citations
Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.
Janet S. Rasey, John R. Grierson, Linda Wiens et al. · PubMed · 2002 · 407 citations
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.
Andreas K. Buck, G. Halter, Holger Schirrmeister et al. · PubMed · 2003 · 404 citations